Join Pete Najarian and special guest, Marc LoPresti, on today's episode of Rebel's Edge as they discuss stocks including Oracle continuing to reap the benefits of the data wave, On Holdings taking a hit, Acadia Therapeutics abandoning trials for Pimavanserin, and Southwest Airlines dipping on news of revised guidance. Gain a deeper understanding of these stocks as Marc and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about NFL free agency and the draft. Stay on the cutting edge with Rebel's Edge.